# Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo

> **NCT01333410** · PHASE4 · UNKNOWN · sponsor: **Mahidol University** · enrollment: 30 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** tacrolimus ointment
- **DRUG:** Mometasone furoate

## Key facts

- **NCT ID:** NCT01333410
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01333410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01333410, "Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01333410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*